4//SEC Filing
Dahms Bradford D. 4
Accession 0001104659-22-123686
CIK 0001745020other
Filed
Nov 30, 7:00 PM ET
Accepted
Dec 1, 4:35 PM ET
Size
5.3 KB
Accession
0001104659-22-123686
Insider Transaction Report
Form 4
Dahms Bradford D.
Chief Financial Officer
Transactions
- Purchase
Common Stock
2022-11-30$6.66/sh+1,502.189$10,000→ 6,142.225 total
Footnotes (2)
- [F1]The price reported is a weighted average price of shares purchased. These shares were purchased in multiple transaction at prices ranging from $6.56 to $6.70, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.
- [F2]Includes 1,162 shares and 1,508 shares previously purchased under the Issuer's 2021 Employee Stock Purchase Plan on May 13, 2022 and November 14, 2022, respectively.
Documents
Issuer
Theseus Pharmaceuticals, Inc.
CIK 0001745020
Entity typeother
Related Parties
1- filerCIK 0001787307
Filing Metadata
- Form type
- 4
- Filed
- Nov 30, 7:00 PM ET
- Accepted
- Dec 1, 4:35 PM ET
- Size
- 5.3 KB